Cargando…
Mesenchymal stem cells against intestinal ischemia–reperfusion injury: a systematic review and meta-analysis of preclinical studies
BACKGROUND: Intestinal ischemia–reperfusion injury (IRI) causes localized and distant tissue lesions. Multiple organ failure is a common complication of severe intestinal IRI, leading to its high rates of morbidity and mortality. Thus far, this is poorly treated, and there is an urgent need for new...
Autores principales: | Shi, Yajing, Zhang, Xiaolan, Wan, Zhanhai, Liu, Xin, Chen, Feng, Zhang, Jianmin, Leng, Yufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137086/ https://www.ncbi.nlm.nih.gov/pubmed/35619154 http://dx.doi.org/10.1186/s13287-022-02896-y |
Ejemplares similares
-
Exosomes derived from bone marrow mesenchymal stem cells regulate pyroptosis via the miR-143-3p/myeloid differentiation factor 88 axis to ameliorate intestinal ischemia-reperfusion injury
por: Wan, Zhanhai, et al.
Publicado: (2023) -
Protective effect of Shenfu injection preconditioning on lung ischemia-reperfusion injury
por: Zhang, Hong, et al.
Publicado: (2016) -
miRNA155-5P participated in DDX3X targeted regulation of pyroptosis to attenuate renal ischemia/reperfusion injury
por: Zhang, Yan, et al.
Publicado: (2023) -
The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injury
por: Yan, Xue-Tao, et al.
Publicado: (2019) -
The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
por: Zhang, Xue-kang, et al.
Publicado: (2015)